Insulin drops for faster healing after corneal crosslinking
Treatments studied
Part of Eyes & vision clinical trials.
This trial tests whether insulin eye drops can help the cornea heal faster after corneal crosslinking, a procedure to treat keratoconus. It is for people with keratoconus who do not have diabetes, severe dry eye, or certain other eye conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have keratoconus and are planning to have corneal crosslinking (a procedure to strengthen your cornea).
- You do not have diabetes.
- You do not have severe dry eye.
- You do not have limbal stem cell deficiency (a condition that affects the eye's surface healing).
- You do not have glaucoma.
- You are not allergic to insulin or methylcellulose (a common eye drop ingredient).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways to manage inflammation after corneal crosslinking for keratoconus: a tiny steroid insert placed in the tear duct versus standard steroid eye drops. It aims to see which option is easier and works just as well.
This study tests a same-day procedure that strengthens the cornea (the clear front part of the eye) in both eyes using a special light treatment, called cross-linking. It may help slow or stop the progression of keratoconus, a condition where the cornea becomes cone-shaped and causes blurry vision.
This trial studies collagen cross-linking, a procedure meant to strengthen a weakened cornea in people with keratoconus. It may help slow the bulging/weakening of the cornea and improve vision, and the study also uses special imaging to check changes over time.
This study tests a lab-grown (ex vivo) method of strengthening donor cornea tissue used in cornea transplants for people with keratoconus. It may help improve how well the transplanted cornea heals and functions.
This study measures how eye pressure changes after corneal cross-linking, a procedure that strengthens a weakened cornea. Researchers will use special imaging to track these changes in patients with early-stage keratoconus (a condition where the cornea thins and bulges).
This trial tests whether a special insulin eye drop can help heal the clear front part of your eye (cornea) faster after PRK laser vision correction. If you are having PRK for nearsightedness or astigmatism and have no other eye problems or conditions like diabetes, you may be able to join.
Hear when a new Keratoconus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.